Skip to main content
. 2021 Sep 19;11(9):1242. doi: 10.3390/brainsci11091242

Table 2.

Correlations between outcome variables and demographic, clinical, treatment and outcome variables.

Outcome Variables
Variables BMI improvement LOS
Demographic variables
Sex p = 1.000 p = 1.000
Age at admission rho = −0.416, p < 0.001 rho = 0.087, p = 0.445
Clinical variables at admission
DUI rho = −0.248, p = 0.027 rho = 0.162, p = 0.155
Admission BMI rho = −0.401, p < 0.001 rho = −0.179, p = 0.122
Admission EDRC rho = −0.174, p = 0.265 rho = −9.8−4, p = 0.995
Diagnosis p = 1.000 p = 1.000
OCD p = 0.262 p = 0.044
PD p = 1.000 p = 1.000
MDD p = 0.741 p = 0.382
Treatment variables
Early AAP p = 0.622 p < 0.001
Early NGT p = 0.365 p = 0.161
SSRI p = 0.037 p = 0.011
Fluvoxamine p = 0.260 p = 0.289
Sertraline p = 0.415 p = 0.252
Fluoxetine p = 0.710 p = 0.155
Outcome variables
BMI improvement / rho = 0.200, p = 0.075
LOS rho = 0.200, p = 0.075 /

Abbreviations: BMI: body-mass index; EDI-3: Eating Disorders Inventory-3; EDRC: eating disorders risk; MDD: major depressive disorder; SSRI: selective serotonin reuptake inhibitors; LOS: length of in-hospital stay; OCD: obsessive-compulsive disorder; PD: panic disorder. Note: Bonferroni corrected significance values: demographic variables: 0.05/2 = 0.025; clinical variables: 0.05/7 = 0.007; treatment variables: 0.05/6 = 0.008; outcomes variables: 0.05/2 = 0.025. Statistically significant results marked in bold and underlined.